Pharmacogenomics; Patient Care

Pharmacogenomics: A Practical Approach for the Health Care Team (Part 1)
CME (AMA PRA Category 1 Credits™) 1.25; ACPE (UAN: 0853-9999-17-045-L01-P) 1.25

Saturday, October 7
12:30 PM - 1:15 PM

Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, has reached the translational stage for various specialties in medicine. Over thirty years of research has led to promising advances in the clinical practice. This conference provides the background, resources and practical application examples to implement pharmacogenomics and make a difference in patient lives. Mayo Clinic experts, with experience leading the implementation of PGx, will provide practical guidance on a range of topics, background and research including: when to order testing, drug/gene selection, informatics, and case study working sessions.

Saturday, October 7th, 2017
12:00 pm Registration and Refreshments
12:30 pm Introductions & Welcome
Pharmacogenomics: From Bench to Bedside Part I
• Describe current key principles for incorporating pharmacogenomics into patient care
• Identify pharmacogenomic testing options and application in clinical situations
• Implement the clinical review and interpretation of pharmacogenomic test results at the bedside

12:40 pm 1. Pharmacogenomics Update (PGx)
Richard Weinshilboum, M.D.
1:10 pm Q&A
1:20 pm 2. Pharmacogenomics 101: A Brief Review
Christine Formea, Pharm.D., R.Ph.
1:40 pm 3. Pharmacogenomics from the Lab Medicine Perspective
Ann M. Moyer, M.D., Ph.D.
2:10 pm Q&A
2:20 pm Break
2:40 pm 4. How to Interpret the PGx Report
Eric Matey, Pharm.D., R.Ph.
3:10 pm Q&A

Learning Objectives:

Richard Weinshilboum

Professor of Medicine and Pharmacology, Chair-Clinical Pharmacology
Mayo Clinic
Mayo Medical School-Mayo Clinic

Richard Weinshilboum, MD, joined the staff of Mayo Clinic in Rochester in 1972 after earning his M.D. degree at the University of Kansas School of Medicine. He completed residency training in internal medicine at Massachusetts General Hospital and a postdoctoral research fellowship at the National Institutes of Health in the laboratory of Nobel laureate Julius Axelrod.

He holds the academic rank of Professor of Medicine and Pharmacology at Mayo Clinic College of Medicine and he holds the Mary Lou and John H. Dasburg Professor of Cancer Genomics.

Dr. Weinshilboum is recognized as an internationally renowned medical investigator, with more than 400 peer-reviewed articles and chapters and many awards, including the Mayo Distinguished Investigator and Distinguished Educator awards.

His research has focused on pharmacogenetics and pharmacogenomics, study of the role of inheritance in individual variation in response to drugs. His research resulted in the discovery and characterization of a series of clinically important genetic polymorphisms (variations in DNA sequence involved in drug, neurotransmitter and hormone metabolism), the functional characterization of these common genetic polymorphisms, and the rapid translation of that information into clinical studies designed to test hypotheses with regard to individual variation in drug response or disease pathophysiology.

This research has also made it possible to develop molecular tests that help protect patients from life-threatening, genetically mediated adverse drug reactions.

Dr. Weinshilboum has chaired the Pharmacogenomics Research Network, a National Institutes of Health-funded initiative that includes scientists from Mayo Clinic, Harvard University and Stanford University, among others. This group of network scientists performs collaborative studies of the role of inheritance in variation in drug response.

He is past member of the advisory councils for the National Institute of General Medical Sciences and the National Human Genome Research Institute, sponsor of the Human Genome Project.


Send Email for Richard Weinshilboum

Christine M. Formea

Pharmacogenomics MTM Pharmacist
Mayo Clinic

Christine Formea, PharmD, BCPS, FCCP, FASHP is a Pharmacogenomics Medication Therapy Management (MTM) Pharmacist at Mayo Clinic in Rochester, Minnesota, and she is an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine. She received her Bachelor of Science from the University of Colorado Skaggs School of Pharmacy and Doctor of Pharmacy from the University of Texas at Austin and University of Texas Health Science Center at San Antonio. She completed a critical care specialty residency at Detroit Receiving Hospital and University Health Center followed by completion of a fellowship in transplant pharmacogenomics at the University of Florida at Gainesville. Dr. Formea is a Board Certified Pharmacotherapy Specialist. Her current research interests focus on clinical translation and implementation of individualized medicine and development of effective pharmacogenomics education programs for health care providers.


Send Email for Christine Formea

Ann Moyer

Senior Associate Consultant, Department of Laboratory Medicine and Pathology
Mayo Clinic

Ann Moyer, MD, PhD, is a co-Director of the Personalized Genomics Laboratory at Mayo Clinic. The Personalized Genomics Laboratory specializes in genetic testing for pharmacogenomics, cardiovascular diseases, and primary immunodeficiencies. Dr. Moyer is a consultant in the Department of Laboratory Medicine and Pathology where she holds the academic rank of Assistant Professor. She earned her medical and graduate degrees as part of the Mayo Clinic Medical Scientist Training Program. Her thesis work focused on pharmacogenomics of phase II drug metabolizing enzymes. She completed residency training in Anatomic and Clinical Pathology, with an additional year devoted to research, followed by a fellowship in Molecular Genetic Pathology, also at the Mayo Clinic.


Send Email for Ann Moyer

Eric Matey

Mayo Clinic

Eric Teye Matey PharmD, RPh, BCACP, has been a pharmacist at Mayo Clinic since graduating from Howard University School of Pharmacy in 2004. From 2006 through 2009, he worked with Mayo Specialty Pharmacist in charge of Growth Hormone Deficiency, Primary Immune Deficiency and Hepatitis C. In this capacity, he collaborated with specialists in these fields to ensure appropriate medication dosing and patient education for optimal medication experience. In 2009, he began working within the clinic as a Medication Therapy Management (MTM) pharmacist with interest in pharmacogenomics and Macrobacterium Avium Complex (MAC). He became a Board Certified Ambulatory Care Pharmacist (BCACP) in 2012, the second year that the Board of Pharmacy Specialties offered the ambulatory care specialty exam. Dr. Eric Teye Matey volunteer at the salvation clinic in the past with Dr. Robert Hoel with a focus on diabetes education and medication management for underserved patient population in Rochester MN. In his spare time, he enjoys biking and as captain of Team Humphrey’s (Tour de Cure-ADA) continues to raise funds for diabetes research and awareness. He is a board member of Africa Partners Medical, a nonprofit organization, which primary goal is to stop needless death in Africa. Professional memberships include MPhA, APhA, ACCP and ASHP.


Send Email for Eric Matey


Pharmacogenomics: A Practical Approach for the Health Care Team (Part 1)
CME (AMA PRA Category 1 Credits™) 1.25; ACPE (UAN: 0853-9999-17-045-L01-P) 1.25

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Pharmacogenomics: A Practical Approach for the Health Care Team (Part 1)
CME (AMA PRA Category 1 Credits™) 1.25; ACPE (UAN: 0853-9999-17-045-L01-P) 1.25